- Home
- NMG vs PALI Comparison
NMG vs PALI Comparison
Compare NMG & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMG | PALI |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.7M | 359.7M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NMG | PALI |
|---|---|---|
| Price | $1.50 | $2.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $5.75 | ★ $11.29 |
| AVG Volume (30 Days) | 350.6K | ★ 1.8M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $1.26 | $0.55 |
| 52 Week High | $6.06 | $2.86 |
Technical Indicators
Market Signals| Indicator | NMG | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 55.28 | 53.13 |
| Support Level | $1.39 | $1.58 |
| Resistance Level | $1.67 | $2.20 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 90.24 | 61.67 |
Price Performance
Historical ComparisonAbout NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.